Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes
Open Access
- 18 January 2017
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 40 (3), 359-366
- https://doi.org/10.2337/dc16-1794
Abstract
OBJECTIVE: The objective of this study was to determine the safety, feasibility, and efficacy of a predictive hyperglycemia and hypoglycemia minimization (PHHM) system compared with predictive low-glucose insulin suspension (PLGS) alone in overnight glucose control. RESEARCH DESIGN AND METHODS: A 42-night trial was conducted in 30 individuals with type 1 diabetes in the age range 15–45 years. Participants were randomly assigned each night to either PHHM or PLGS and were blinded to the assignment. The system suspended the insulin pump on both the PHHM and PLGS nights for predicted hypoglycemia but delivered correction boluses for predicted hyperglycemia on PHHM nights only. The primary outcome was the percentage of time spent in a sensor glucose range of 70–180 mg/dL during the overnight period. RESULTS: The addition of automated insulin delivery with PHHM increased the time spent in the target range (70–180 mg/dL) from 71 ± 10% during PLGS nights to 78 ± 10% during PHHM nights (P < 0.001). The average morning blood glucose concentration improved from 163 ± 23 mg/dL after PLGS nights to 142 ± 18 mg/dL after PHHM nights (P < 0.001). Various sensor-measured hypoglycemic outcomes were similar on PLGS and PHHM nights. All participants completed 42 nights with no episodes of severe hypoglycemia, diabetic ketoacidosis, or other study- or device-related adverse events. CONCLUSIONS: The addition of a predictive hyperglycemia minimization component to our existing PLGS system was shown to be safe, feasible, and effective in overnight glucose control.Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-085591)
- JDRF (22-2013-266)
- JDRF (80-2010-585)
- Stanford Clinical and Translational Science Award (UL1 TR001085)
This publication has 35 references indexed in Scilit:
- Outpatient Safety Assessment of an In-Home Predictive Low-Glucose Suspend System with Type 1 Diabetes Subjects at Elevated Risk of Nocturnal HypoglycemiaDiabetes Technology & Therapeutics, 2013
- Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 DiabetesDiabetes Care, 2013
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes CampThe New England Journal of Medicine, 2013
- The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 DiabetesDiabetes Care, 2012
- Hypoglycemia Does Not Change the Threshold for Arousal from Sleep in Adolescents with Type 1 DiabetesDiabetes Technology & Therapeutics, 2012
- Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesBMJ, 2011
- Duration of Nocturnal Hypoglycemia Before SeizuresDiabetes Care, 2008
- Response to Nocturnal Alarms Using a Real-Time Glucose SensorDiabetes Technology & Therapeutics, 2005
- Decreased Epinephrine Responses to Hypoglycemia during SleepThe New England Journal of Medicine, 1998
- The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility PhaseDiabetes, 1986